Free Trial

Severfield (SFR) Competitors

Severfield logo
GBX 19.20 -1.50 (-7.25%)
As of 11:50 AM Eastern

SFR vs. TRX, NAK, EGI, IMG, EDG, MTA, NGR, RRS, NG, and WPM

Should you be buying Severfield stock or one of its competitors? The main competitors of Severfield include Tissue Regenix Group (TRX), Nakama Group plc (NAK.L) (NAK), (EGI.L) (EGI), 532753 (IMG.L) (IMG), 651814 (EDG.L) (EDG), ArcelorMittal (MTA), Nature Group (NGR), Randgold Resources (RRS), National Grid (NG), and Wheaton Precious Metals (WPM). These companies are all part of the "precious metals" industry.

Severfield vs.

Tissue Regenix Group (LON:TRX) and Severfield (LON:SFR) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability, media sentiment and community ranking.

Severfield received 64 more outperform votes than Tissue Regenix Group when rated by MarketBeat users. Likewise, 76.09% of users gave Severfield an outperform vote while only 69.53% of users gave Tissue Regenix Group an outperform vote.

CompanyUnderperformOutperform
Tissue Regenix GroupOutperform Votes
162
69.53%
Underperform Votes
71
30.47%
SeverfieldOutperform Votes
226
76.09%
Underperform Votes
71
23.91%

Severfield has higher revenue and earnings than Tissue Regenix Group. Tissue Regenix Group is trading at a lower price-to-earnings ratio than Severfield, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tissue Regenix Group£31.98M1.04-£1.11M-£0.97-38.20
Severfield£444.13M0.13£15.24M£5.253.66

Tissue Regenix Group has a beta of 1.61, meaning that its stock price is 61% more volatile than the S&P 500. Comparatively, Severfield has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500.

Severfield has a net margin of 3.43% compared to Tissue Regenix Group's net margin of -3.46%. Severfield's return on equity of 7.24% beat Tissue Regenix Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Tissue Regenix Group-3.46% -2.87% 0.50%
Severfield 3.43%7.24%4.69%

37.0% of Tissue Regenix Group shares are owned by institutional investors. Comparatively, 66.9% of Severfield shares are owned by institutional investors. 47.3% of Tissue Regenix Group shares are owned by insiders. Comparatively, 4.4% of Severfield shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Severfield had 1 more articles in the media than Tissue Regenix Group. MarketBeat recorded 1 mentions for Severfield and 0 mentions for Tissue Regenix Group. Tissue Regenix Group's average media sentiment score of 0.00 equaled Severfield'saverage media sentiment score.

Company Overall Sentiment
Tissue Regenix Group Neutral
Severfield Neutral

Summary

Severfield beats Tissue Regenix Group on 11 of the 14 factors compared between the two stocks.

Remove Ads
Get Severfield News Delivered to You Automatically

Sign up to receive the latest news and ratings for SFR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SFR vs. The Competition

MetricSeverfieldEngineering & Construction IndustryIndustrials SectorLON Exchange
Market Cap£56.07M£2.08B£6.71B£2.52B
Dividend Yield7.41%3.16%3.56%4.90%
P/E Ratio3.6626.8820.33134.65
Price / Sales0.1330.7475.02261,054.86
Price / Cash16.9413.7926.8327.90
Price / Book0.272.333.594.45
Net Income£15.24M£76.87M£796.18M£5.77B
7 Day Performance-11.93%-1.88%-2.68%-1.85%
1 Month Performance-25.87%0.51%-2.38%-2.65%
1 Year Performance-65.96%65.33%10.43%103.94%

Severfield Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SFR
Severfield
N/AGBX 19.20
-7.2%
N/A-63.3%£56.07M£444.13M3.661,900Dividend Cut
Gap Up
TRX
Tissue Regenix Group
N/AGBX 37.90
-0.3%
N/A-37.9%£34.17M£31.98M-39.13120Gap Down
NAK
Nakama Group plc (NAK.L)
N/AN/AN/AN/A£1.44M£8.09M-6.1353Gap Down
High Trading Volume
EGI
(EGI.L)
N/AN/AN/AN/A£0.00N/A0.006Gap Down
High Trading Volume
IMG
532753 (IMG.L)
N/AN/AN/AN/A£0.00N/A0.005,360High Trading Volume
EDG
651814 (EDG.L)
N/AN/AN/AN/A£0.00N/A0.002,610
MTA
ArcelorMittal
N/AN/AN/AN/A£0.00N/A0.009News Coverage
High Trading Volume
NGR
Nature Group
N/AN/AN/AN/A£0.00N/A0.0010Gap Up
RRS
Randgold Resources
N/AN/AN/AN/A£0.00N/A0.0021,300Gap Up
NG
National Grid
1.6967 of 5 stars
GBX 1,009.50
flat
GBX 1,181.25
+17.0%
N/A£49.56B£25.99B16.5910High Trading Volume
WPM
Wheaton Precious Metals
1.2823 of 5 stars
GBX 5,960
+0.2%
GBX 5,900
-1.0%
+54.4%£33.47B£1.51B54.9142Positive News
Remove Ads

Related Companies and Tools


This page (LON:SFR) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners